News | November 12, 2021
Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
Evidence also shows better immune response to virus among users of spray
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
The Lucent 3D Lumbar Interbody System features a functionally unique multi-component device manufactured in a 3D printing sequence
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
Biocon Biologics and Viatris co-developed the products
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
Subscribe To Our Newsletter & Stay Updated
